1319503 BACH2 BTB domain and CNC homolog 2 6 89926528 90296843 Human
Peak: (rs1504215 )
Human Assembly Chr Position (strand) Source GRCh38 6 90,296,508 - 90,296,509 RGD_MAPPER_PIPELINE
597110327 GWAS1206401_H Inhalant adrenergic use measurement QTL GWAS1206401 (human) 1e-18 Inhalant adrenergic use measurement 6 90296508 90296509 Human 597056021 GWAS1152095_H basophil count QTL GWAS1152095 (human) 2e-10 basophil quantity (VT:0002607) blood basophil count (CMO:0000034) 6 90296508 90296509 Human 407249600 GWAS898576_H asthma QTL GWAS898576 (human) 2e-46 asthma 6 90296508 90296509 Human 597109600 GWAS1205674_H Glucocorticoid use measurement QTL GWAS1205674 (human) 1e-13 Glucocorticoid use measurement 6 90296508 90296509 Human 597326146 GWAS1422220_H FEV/FVC ratio QTL GWAS1422220 (human) 2e-11 FEV/FVC ratio forced expiratory volume to forced vital capacity ratio (CMO:0000241) 6 90296508 90296509 Human 1298426 BFD3_H Body fluid distribution QTL 3 (human) 2.79 0.01 Body fluid distribution impedance ratio 6 84873647 110873647 Human 597048956 GWAS1145030_H allergic rhinitis QTL GWAS1145030 (human) 2e-18 allergic rhinitis 6 90296508 90296509 Human
Data has come from the GWAS Catalog
The highlighted row represents the current QTL
GWAS1152095_H
GCST90002296
Basophil count
577,663 African American or Afro-Caribbean, African ancestry, European ancestry, East Asian ancestry, Hispanic or Latin American and South Asian ancestry individuals
A
0.338542
2E-10
9.699
rs1504215
N/A
basophil count (EFO:0005090)
PMID:32888493
GWAS1145030_H
GCST006409
Allergic rhinitis
59,762 European and unknown ancestry cases, 152,358 European and unknown ancestry controls
G
0.6575
2E-18
17.699
rs1504215
1.0526316
allergic rhinitis (EFO:0005854)
PMID:30013184
GWAS1205674_H
GCST007942
Medication use (glucocorticoids)
17,352 European ancestry cases, 188,348 European ancestry controls
A
0.350757
1E-13
13
rs1504215
0.08696847
Glucocorticoid use measurement (EFO:0009942)
PMID:31015401
GWAS1206401_H
GCST007941
Medication use (adrenergics, inhalants)
28,880 European ancestry cases, 147,565 European ancestry controls
A
0.349167
1E-18
18
rs1504215
0.083247945
Inhalant adrenergic use measurement (EFO:0009941)
PMID:31015401
GWAS1734025_H
GCST90002363
Red blood cell count
545,203 European ancestry individuals
A
0.346442
2E-24
23.699
rs1504215
0.019813
red blood cell density (OBA:2045260)
PMID:32888493
GWAS898576_H
GCST010043
Asthma
84,492 European ancestry cases, 2,149 African American cases, 606 Hispanic cases, 1,239 Japanese ancestry cases, 437,036 European ancestry controls, 6,055 African American controls, 792 Hispanic controls, 3,976 Japanese ancestry controls
G
0.66
2E-46
45.699
rs1504215
N/A
PMID:32296059
None Available
GCST90018999
Medication use (adrenergics, inhalants)
28,880 European ancestry cases, 147,565 European ancestry controls, 5,880 East Asian ancestry cases, 172,846 East Asian ancestry controls
A
NR
1E-18
18
rs1504215
0.0832
Inhalant adrenergic use measurement (EFO:0009941)
PMID:34594039
None Available
GCST90019000
Medication use (glucocorticoids)
17,352 European ancestry cases, 188,348 European ancestry controls, 13,102 East Asian ancestry cases, 165,624 East Asian ancestry controls
A
NR
1E-13
13
rs1504215
0.087
Glucocorticoid use measurement (EFO:0009942)
PMID:34594039
GWAS1422220_H
GCST90244094
Lung function (FEV1/FVC)
475,645 European ancestry individuals, 8,590 African ancestry individuals, 85,279 East Asian ancestry individuals, 4,270 South Asian ancestry individuals, 14,668 Hispanic or Latin American individuals
A
0.289
2E-11
10.699
rs1504215
6.74
FEV/FVC ratio (EFO:0004713)
PMID:36914875